 |
Webcast Alert: Aastrom Announces Third Quarter Investor Conference Call
May 8, 2008
|
9.5 KB |
|
| |
ANN ARBOR, Mich., May 08, 2008 (BUSINESS WIRE) -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast:
What: Aastrom Biosciences, Inc. Third Quarter Fiscal Year 2008 Investor Conference Call
When: Monday, May 12, 2008 @ 4:15 pm (Eastern)
Where: http://www.investorcalendar.com/IC/CEPage.asp?ID=128408
How:
-- ...
|
|
Aastrom Biosciences Board of Directors Withdraws Reverse Stock Split Proposal
May 5, 2008
|
10.4 KB |
|
| |
ANN ARBOR, Mich., May 5, 2008 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that its Board of Directors will withdraw its proposal to shareholders for approval of the grant of discretionary authority to Aastrom's Board of Directors to amend the Company's ...
|
|
Aastrom Event Reminder: Q&A Sessions Regarding Shareholder Proposal
Apr 23, 2008
|
9.2 KB |
|
| |
ANN ARBOR, Mich., Apr 23, 2008 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) will host two one-hour telephone Question & Answer sessions to provide further clarity on the proposal to amend the Company's Restated Articles of Incorporation to position the Company's Board of Directors to consider and execute a pote...
|
|
Encouraging Clinical Data Reported From Aastrom's First EU Compassionate Use Cardiac Patients
Apr 17, 2008
|
12.3 KB |
|
| |
ANN ARBOR, Mich., Apr 17, 2008 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced encouraging data from the first two compassionate use patients treated with the Company's autologous stem cell therapy for dilated cardiomyopathy (DCM), a type of severe chronic ...
|
|
Aastrom Biosciences Adjourns Special Meeting Until May 6, 2008; Board Urges Shareholders to Vote for the Proposal Considered Critical to the Future of the Company
Apr 8, 2008
|
12.2 KB |
|
| |
ANN ARBOR, Mich., Apr 8, 2008 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that the Company's Special Meeting of Shareholders was adjourned and will reconvene on Tuesday, May 6, 2008 at 9:00am (EDT), at Aastrom's office, 24 Frank Lloyd Wright Drive, Lobb...
|
|
Aastrom Biosciences Intends to Seek Shareholder Approval to Grant Board Authority to Amend Restated Articles of Incorporation
Feb 22, 2008
|
10.2 KB |
|
| |
ANN ARBOR, Mich., Feb 22, 2008 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that the Company intends to seek shareholder approval to authorize the Board of Directors to amend Aastrom's Restated Articles of Incorporation to execute a reverse split of the ...
|
|
Aastrom Biosciences Announces Transition of Duties
Feb 15, 2008
|
10.3 KB |
|
| |
ANN ARBOR, Mich., Feb 15, 2008 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that Gerald D. Brennan, Jr., Vice President, Administrative & Financial Operations and Chief Financial Officer, has announced his intention to retire from the Company and has req...
|
|
Aastrom Reports Second Quarter Fiscal Year 2008 Financial Results
Feb 8, 2008
|
17.9 KB |
|
| |
ANN ARBOR, Mich., Feb 8, 2008 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today reported financial results for the second fiscal quarter ended December 31, 2007. The Company also reported several clinical achievements since the beginning of the second fiscal quarter, i...
|
|
Webcast Alert: Aastrom Announces Second Quarter Investor Conference Call
Jan 31, 2008
|
9.5 KB |
|
| |
ANN ARBOR, Mich., Jan 31, 2008 (BUSINESS WIRE) -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast:
What: Aastrom Biosciences, Inc. Second Quarter Fiscal Year 2008 Investor Conference Call
When: Friday, February 8, 2008 @ 9:00 am (Eastern)
Where: http://www.vcall.com/IC/CEPage.asp?ID=125365
How: -- For live I...
|
|
Aastrom Biosciences to Present At Leerink Swann Novel Biologics Therapeutics Roundtable Conference
Jan 17, 2008
|
9.6 KB |
|
| |
ANN ARBOR, Mich., Jan 17, 2008 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM) ), a leading regenerative medicine company, today announced that George Dunbar, President and Chief Executive Officer, will participate in the Leerink Swann Novel Biologics Therapeutics Roundtable Conference on Thursday, January 24, 200...
|
|
Aastrom Announces First Patient Treatment With Autologous Stem Cell Therapy for Heart Failure
Jan 15, 2008
|
11.2 KB |
|
| |
ANN ARBOR, Mich., Jan 15, 2008 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that the first patient has been treated with the Company's autologous stem cell therapy for dilated cardiomyopathy (DCM). The milestone marks the first human application of Aastr...
|
|
Aastrom Biosciences Receives Notice Related to NASDAQ Minimum Closing Bid Price Rule
Dec 21, 2007
|
10.5 KB |
|
| |
ANN ARBOR, Mich., Dec 21, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that on December 20, 2007, the Company received a deficiency letter from The Nasdaq Stock Market indicating that the minimum closing bid price of its common stock had fallen belo...
|
|
Aastrom Biosciences to Present At RBC Capital Markets Healthcare Conference
Dec 7, 2007
|
9.7 KB |
|
| |
ANN ARBOR, Mich., Dec 7, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that George Dunbar, President and Chief Executive Officer, will participate in the Biomaterials: Helping The Body Regenerate Bone & Tissue panel on Thursday, December 13, 2007 at ...
|
|
Aastrom Biosciences to Present At BMO Capital Markets Healthcare Conference
Nov 29, 2007
|
9.9 KB |
|
| |
ANN ARBOR, Mich., Nov 29, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that George Dunbar, President and Chief Executive Officer, will present at the 2007 BMO Capital Markets Focus on Healthcare Conference. The conference will be held December 4-5th...
|
|
Aastrom Biosciences, Inc. Reports First Quarter Fiscal Year 2008 Financial Results
Nov 9, 2007
|
18.0 KB |
|
| |
ANN ARBOR, Mich., Nov 9, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today reported financial results for the first fiscal quarter ended September 30, 2007. The Company also reported clinical and operational achievements since the beginning of fiscal year 2008, in...
|
|
Webcast Alert: Aastrom Announces First Quarter Investor Conference Call
Nov 5, 2007
|
9.5 KB |
|
| |
ANN ARBOR, Mich., Nov 05, 2007 (BUSINESS WIRE) -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast:
What: Aastrom Biosciences, Inc. First Quarter Fiscal Year 2008 Investor Conference Call
When: Friday, November 9, 2007 @ 9:00 am (Eastern)
Where: http://www.vcall.com/IC/CEPage.asp?ID=122490
How: -- For live In...
|
|
Webcast Alert: Aastrom Biosciences Announces Webcast for Annual Meeting of Shareholders
Oct 31, 2007
|
9.1 KB |
|
| |
ANN ARBOR, Mich., Oct 31, 2007 (BUSINESS WIRE) -- Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast:
What: Aastrom Biosciences Fiscal Year 2007 Annual Meeting of Shareholders
When: Wednesday, November 7, 2007 @ 9:00 am (Eastern)
Where: http://www.vcall.com/IC/CEPage.asp?ID=122044
How: For live Internet access, simpl...
|
|
Aastrom Biosciences to Present At Acumen Biofin Rodman & Renshaw 9th Annual Healthcare Conference
Oct 30, 2007
|
10.7 KB |
|
| |
ANN ARBOR, Mich., Oct 30, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced that Gerald D. Brennan, Vice President, Administrative and Financial Operations and Chief Financial Officer and Elmar R. Burchardt, MD, PhD, Vice President, Medical Affairs, will...
|
|
Aastrom Stem Cell Therapy Demonstrates Positive Results in Severe Long Bone Non-Union Fracture Trial
Oct 18, 2007
|
14.7 KB |
|
| |
ANN ARBOR, Mich., Oct 18, 2007 (PrimeNewswire via COMTEX News Network) -- Aastrom Biosciences, Inc. (Nasdaq:ASTM), a leading regenerative medicine company, today announced final results from a U.S. Phase I/II clinical trial designed to collect safety and efficacy data utilizing Bone Repair Cells (BRCs) in the treatment of severe non-union fractures...
|
|
Webcast Alert: Aastrom Announces Conference Call to Discuss the Results from the U.S. Phase I/II Severe Fracture Trial
Oct 16, 2007
|
9.5 KB |
|
| |
ANN ARBOR, Mich., Oct 16, 2007 (BUSINESS WIRE) -- Aastrom Biosciences, Inc. (NASDAQ: ASTM) announces the following Webcast:
What: Aastrom Biosciences, Inc. Conference Call to Discuss the Results from the U.S. Phase I/II Severe Fracture Trial
When: Monday, October 22, 2007 at 9:00 am (EDT)
Where: http://www.vcall.com/IC/CEPage.asp?ID=122...
|
|
|
